Printer friendly version Share

News Release

Patients with aberrations in two genes respond better to drugs blocking a well-known cancer pathway

06 November 2012 The European CanCer Organisation (ECCO)

Please login or register to view articles older than 3 months

Science Daily Elhuyar with Basque FNSF ad expertsvar 2015 Cambridge blue millet New Norwegian logo eNEWS6